AMRX Operating Cash Flow (Statement)
Amneal Pharmaceuticals Inc Class A · Operating Cash Flow (Statement)
AMRX Operating Cash Flow (Statement)
Latest reported-$19.26Mperiod ending
AMRX Quarterly Cash from Operations ($36.37M → -$19.26M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
AMRX operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -19,262,000 | |
| -28,725,000 | |
| 130,315,000 | |
| 118,450,000 | |
| 83,819,000 | |
| 7,408,000 | |
| 118,078,000 | |
| 141,774,000 | |
| 39,657,000 | |
| -4,410,000 | |
| 135,823,000 | |
| 81,387,000 | |
| -11,345,000 | |
| 139,712,000 | |
| -23,292,000 | |
| 93,570,000 | |
| -125,521,000 | |
| 76,345,000 | |
| 63,261,000 | |
| 82,364,000 | |
| -51,933,000 | |
| 148,128,000 | |
| 105,958,000 | |
| 44,776,000 | |
| 179,241,000 | |
| 49,026,000 | |
| -50,889,000 | |
| 139,910,000 | |
| 21,094,000 | |
| -108,410,000 | |
| 259,651,000 | |
| 62,129,000 | |
| -98,579,000 | |
| 27,029,000 | |
| 65,265,000 | |
| 73,513,000 | |
| 26,001,000 | |
| 69,408,000 | |
| 36,374,000 |